Saie Yoin Choi
Sports Medicine · Rocklin, CANPI 1073116356
Payments from drug & device makers
Across 211 payments — averaging $19.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$643
- Pfizer$496
- Novo Nordisk$493
- Lilly USA, LLC$356
- AstraZeneca$274
- Amgen$241
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,051100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $643 |
| Pfizer | 30 | $496 |
| Novo Nordisk | 26 | $493 |
| Lilly USA, LLC | 20 | $356 |
| AstraZeneca | 14 | $274 |
| Amgen | 12 | $241 |
| GSK | 12 | $217 |
| Exact Sciences | 7 | $154 |
| Astellas Pharma US Inc | 7 | $134 |
| Boston Scientific | 5 | $109 |
| Merck | 6 | $92 |
| Boehringer Ingelheim | 4 | $81 |
| Phathom Pharmaceuticals, Inc. | 3 | $79 |
| Kowa Pharmaceuticals America, Inc. | 4 | $62 |
| IBSA Pharma Inc. | 3 | $47 |
| Hologic Sales And Service, LLC | 2 | $46 |
| Verity Pharmaceuticals Inc. | 3 | $44 |
| Cranial Technologies, Inc | 2 | $40 |
| Eisai Inc. | 2 | $37 |
| Bayer | 2 | $35 |
| Seqirus USA Inc | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Dexcom, Inc. | 1 | $31 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Novartis | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Medtronic | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Antares Pharma, Inc. | 1 | $19 |
| Halozyme Inc | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Kaleo, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $14 |
How this compares
$4,051 in reported general payments places this provider in the 60th percentile of 662 sports medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $18,739 |
| JardianceEmpagliflozin | 12 | $18,236 |
| Wixela InhubFluticasone Propion/Salmeterol | 12 | $1,140 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 50 | $936 |
| Pregabalin | 24 | $903 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $872 |
| Levothyroxine Sodium | 79 | $834 |
| Atorvastatin Calcium | 61 | $807 |
| Gabapentin | 35 | $677 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $625 |
| Lidocaine | 11 | $567 |
| Lisinopril | 45 | $471 |
| Losartan Potassium | 48 | $403 |
| Estradiol | 12 | $341 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $339 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $496 | $18,73918 claims |
| Boehringer IngelheimJardiance | $81 | $18,23612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 662 sports medicine providers in California.
Other sports medicine in Rocklin
- Neal ElattracheLos Angeles$51M
- Nathaniel CohenLos Gatos$6.4M
- Thomas KnappSanta Monica$2.5M
- Seth ShermanStanford$1.8M
- Michael FreehillStanford$1.7M
- Deryk JonesSan Carlos$1.6M
- Allan MishraMenlo Park$1.5M
- Heinz Hoeneckela Jolla$1.4M
- Marc SafranPalo Alto$1.2M
- Stephan YacoubianBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.